These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38569976)

  • 21. pH-Responsive nanoparticle vaccines for dual-delivery of antigens and immunostimulatory oligonucleotides.
    Wilson JT; Keller S; Manganiello MJ; Cheng C; Lee CC; Opara C; Convertine A; Stayton PS
    ACS Nano; 2013 May; 7(5):3912-25. PubMed ID: 23590591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.
    Bershteyn A; Hanson MC; Crespo MP; Moon JJ; Li AV; Suh H; Irvine DJ
    J Control Release; 2012 Feb; 157(3):354-65. PubMed ID: 21820024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paracrine release of IL-12 stimulates IFN-gamma production and dramatically enhances the antigen-specific T cell response after vaccination with a novel peptide-based cancer vaccine.
    Salem ML; Kadima AN; Zhou Y; Nguyen CL; Rubinstein MP; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
    J Immunol; 2004 May; 172(9):5159-67. PubMed ID: 15100252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of two different PEGylation strategies for the liposomal adjuvant CAF09: Towards induction of CTL responses upon subcutaneous vaccine administration.
    Schmidt ST; Olsen CL; Franzyk H; Wørzner K; Korsholm KS; Rades T; Andersen P; Foged C; Christensen D
    Eur J Pharm Biopharm; 2019 Jul; 140():29-39. PubMed ID: 31055066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.
    Swaminathan G; Thoryk EA; Cox KS; Meschino S; Dubey SA; Vora KA; Celano R; Gindy M; Casimiro DR; Bett AJ
    Vaccine; 2016 Jan; 34(1):110-9. PubMed ID: 26555351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    Vaccine; 2018 Jun; 36(28):4023-4031. PubMed ID: 29861179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
    Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
    Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple antigen peptide consisting of B- and T-cell epitopes of F1 antigen of Y. pestis showed enhanced humoral and mucosal immune response in different strains of mice.
    Ali R; Kumar S; Naqvi RA; Sheikh IA; Rao DN
    Int Immunopharmacol; 2013 Jan; 15(1):97-105. PubMed ID: 23174507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graphene Oxides Decorated with Carnosine as an Adjuvant To Modulate Innate Immune and Improve Adaptive Immunity in Vivo.
    Meng C; Zhi X; Li C; Li C; Chen Z; Qiu X; Ding C; Ma L; Lu H; Chen D; Liu G; Cui D
    ACS Nano; 2016 Feb; 10(2):2203-13. PubMed ID: 26766427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new adjuvanted nanoparticle-based H1N1 influenza vaccine induced antigen-specific local mucosal and systemic immune responses after administration into the lung.
    Neuhaus V; Chichester JA; Ebensen T; Schwarz K; Hartman CE; Shoji Y; Guzmán CA; Yusibov V; Sewald K; Braun A
    Vaccine; 2014 May; 32(26):3216-22. PubMed ID: 24731807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannan-Abeta28 conjugate prevents Abeta-plaque deposition, but increases microhemorrhages in the brains of vaccinated Tg2576 (APPsw) mice.
    Petrushina I; Ghochikyan A; Mkrtichyan M; Mamikonyan G; Movsesyan N; Ajdari R; Vasilevko V; Karapetyan A; Lees A; Agadjanyan MG; Cribbs DH
    J Neuroinflammation; 2008 Sep; 5():42. PubMed ID: 18823564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lignin nanoparticles as a promising vaccine adjuvant and delivery system for ovalbumin.
    Alqahtani MS; Kazi M; Ahmad MZ; Syed R; Alsenaidy MA; Albraiki SA
    Int J Biol Macromol; 2020 Nov; 163():1314-1322. PubMed ID: 32645499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meningococcal PorB induces a robust and diverse antigen specific T cell response as a vaccine adjuvant.
    Mosaheb M; Wetzler LM
    Vaccine; 2018 Nov; 36(50):7689-7699. PubMed ID: 30381152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration routes affect the quality of immune responses: A cross-sectional evaluation of particulate antigen-delivery systems.
    Mohanan D; Slütter B; Henriksen-Lacey M; Jiskoot W; Bouwstra JA; Perrie Y; Kündig TM; Gander B; Johansen P
    J Control Release; 2010 Nov; 147(3):342-9. PubMed ID: 20727926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant.
    Gallovic MD; Montjoy DG; Collier MA; Do C; Wyslouzil BE; Bachelder EM; Ainslie KM
    Biomater Sci; 2016 Mar; 4(3):483-93. PubMed ID: 26753184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical imiquimod is a potent adjuvant to a weakly-immunogenic protein prototype vaccine.
    Johnston D; Bystryn JC
    Vaccine; 2006 Mar; 24(11):1958-65. PubMed ID: 16310898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity.
    Cui Z; Han D; Sun X; Zhang M; Feng X; Sun C; Gu J; Tong C; Lei L; Han W
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):667-80. PubMed ID: 25381907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
    Even MP; Young K; Winter G; Hook S; Engert J
    Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell Penetrating Peptide-Based Redox-Sensitive Vaccine Delivery System for Subcutaneous Vaccination.
    Wang K; Yang Y; Xue W; Liu Z
    Mol Pharm; 2018 Mar; 15(3):975-984. PubMed ID: 29359945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination.
    Bal SM; Hortensius S; Ding Z; Jiskoot W; Bouwstra JA
    Vaccine; 2011 Jan; 29(5):1045-52. PubMed ID: 21129393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.